Who was studied, and how
One number in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 15 other studies
people with type 2 diabetes, in this paper
The trial randomly assignedassigned by chance
lobeglitazone (0.5 mg/day)
placebo
Reported lower long-term blood sugar, no range given−1.03
randomisedthe abstract, start to end
… difference in the adjusted mean change [-1.03%; p < 0.0001].
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
HbA1clobeglitazone (0.5 mg/day) vs placebo
−1.03
ThiazolidinedionesGlycemic control
Thiazolidinediones × glycemic controlhelps?settled
unlikelylikely
0.830.80 without it
← favours treatmentfavours comparator →
1 / 6